Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 5
Submit an article Journal homepage
83
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Burden of illness of hepatitis C from a managed care organization perspective

Edward P. Armstrong College of Pharmacy, University of Arizona, Tucson, AZ, USACorrespondence[email protected]
&
Scott L. Charland Kos Pharmaceuticals, Inc. and School of Pharmacy, University of Colorado, Denver, CO, USA
Pages 671-679 | Accepted 16 Feb 2004, Published online: 12 Mar 2004

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marco daCosta DiBonaventura, Jan-Samuel Wagner, Yong Yuan, Gilbert L’Italien, Paul Langley & W. Ray Kim. (2011) The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. Journal of Medical Economics 14:2, pages 253-261.
Read now
Marco daCosta DiBonaventura, Jan-Samuel Wagner, Yong Yuan, Gilbert L'Italien, Paul Langley & W. Ray Kim. (2010) Humanistic and economic impacts of hepatitis C infection in the United States. Journal of Medical Economics 13:4, pages 709-718.
Read now

Articles from other publishers (14)

Timothy Pham, R. Chris Rathbun, Shellie Keast, Nancy Nesser, Kevin Farmer & Grant Skrepnek. (2018) National estimates of case‐mix, mortality, and economic outcomes among inpatient HIV/AIDS mono‐infection and hepatitis C co‐infection cases in the US. Journal of Evaluation in Clinical Practice 25:5, pages 806-821.
Crossref
Risha Gidwani-Marszowski, Douglas K. Owens, Jeanie Lo, Jeremy D. Goldhaber-Fiebert, Steven M. Asch & Paul G. Barnett. (2019) The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration. Applied Health Economics and Health Policy 17:4, pages 513-521.
Crossref
Milan Milošević, Jelena Jakab, Lucija Kuna & Martina Smolić. 2017. Update on Hepatitis C. Update on Hepatitis C.
Shan LiuPaul G. BarnettMark HolodniyJeanie LoVilija R. JoyceRisha GidwaniSteven M. AschDouglas K. OwensJeremy D. Goldhaber-Fiebert. (2016) Cost-Effectiveness of Treatments for Genotype 1 Hepatitis C Virus Infection in Non-VA and VA Populations. MDM Policy & Practice 1:1, pages 238146831667194.
Crossref
Mudassar Imran, Hassan Rafique, Adnan Khan & Tufail Malik. (2013) A model of bi-mode transmission dynamics of hepatitis C with optimal control. Theory in Biosciences 133:2, pages 91-109.
Crossref
D.A. Axelrod, N. Dzebisashvili, K. Lentine, D.L. Segev, R. Dickson, E. Tuttle-Newhall, R. Freeman & M. Schnitzler. (2014) Assessing Variation in the Costs of Care Among Patients Awaiting Liver Transplantation. American Journal of Transplantation 14:1, pages 70-78.
Crossref
Shan Liu, Lauren E. Cipriano, Mark Holodniy & Jeremy D. Goldhaber-Fiebert. (2013) Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States. PLoS ONE 8:3, pages e58975.
Crossref
Joseph Menzin, Leigh Ann White, Christine Nichols & Baris Deniz. (2012) The economic burden of advanced liver disease among patients with Hepatitis C Virus: a large state Medicaid perspective. BMC Health Services Research 12:1.
Crossref
M. Solomon, M. Bonafede, K. Pan, K. Wilson, C. Beam, P. Chakravarti & B. Spiegel. (2011) Direct Medical Care Costs Among Pegylated Interferon Plus Ribavirin-Treated and Untreated Chronic Hepatitis C Patients. Digestive Diseases and Sciences 56:10, pages 3024-3031.
Crossref
Jeffrey S. McCombs, Yong Yuan, Janet Shin & Sammy Saab. (2011) Economic Burden Associated With Patients Diagnosed With Hepatitis C. Clinical Therapeutics 33:9, pages 1268-1280.
Crossref
N. Z. Janjua, H. B. Hamza, M. Islam, S. F. A. Tirmizi, A. Siddiqui, W. Jafri & S. Hamid. (2010) Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan. Journal of Viral Hepatitis 17:5, pages 317-326.
Crossref
Nyingi Kemmer & Guy W. Neff. (2007) Ethnic Variations in Chronic Liver Diseases. Digestive Diseases and Sciences 53:5, pages 1339-1344.
Crossref
Alistair James Gammie. (2008) For the proposition: for the diagnosis of viral infections, commercial assays provide more reliable results than do in‐house assays. Reviews in Medical Virology 18:2, pages 73-76.
Crossref
Wei‐Shi Yeh, Edward P. Armstrong, Grant H. Skrepnek & Daniel C. Malone. (2012) Peginterferon alfa‐2a versus Peginterferon alfa‐2b as Initial Treatment of Hepatitis C Virus Infection: A Cost‐Utility Analysis from the Perspective of the Veterans Affairs Health Care System. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27:6, pages 813-824.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.